Avonex®: Safety, Blood Levels and Effects

Clinical trial NCT01863069 · COMPLETED

Trial details

NCT number: NCT01863069
Sponsor: Trio Medicines Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis (MS)

Start date: 2001-01-01
Primary completion: 2001-10-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.